114 related articles for article (PubMed ID: 1926582)
21. Kinetic analyses of the activation of Glu-plasminogen by urokinase in the presence of fibrin, fibrinogen or its degradation products.
Watahiki Y; Takada Y; Takada A
Thromb Res; 1987 Apr; 46(1):9-18. PubMed ID: 3590117
[TBL] [Abstract][Full Text] [Related]
22. Comparison of fibrin-mediated stimulation of plasminogen activation by tissue-type plasminogen activator (t-PA) and fibrin-dependent enhancement of amidolytic activity of t-PA.
Fischer BE
Blood Coagul Fibrinolysis; 1992 Apr; 3(2):197-204. PubMed ID: 1606292
[TBL] [Abstract][Full Text] [Related]
23. Initial interaction between fibrin and tissue plasminogen activator (t-PA). The Gly-Pro-Arg-Pro binding site on fibrin(ogen) is important for t-PA activity.
Kaczmarek E; Lee MH; McDonagh J
J Biol Chem; 1993 Feb; 268(4):2474-9. PubMed ID: 8428923
[TBL] [Abstract][Full Text] [Related]
24. [Kinetics of glu- and lys-plasminogen activation by the tissue activator in a fibrin clot].
Makogonenko EM; Kirpa SA; Lugovskoĭ EV; Nazarenko NA; Kudinov SA
Biokhimiia; 1987 Oct; 52(10):1746-52. PubMed ID: 3122854
[TBL] [Abstract][Full Text] [Related]
25. [Plasminogen-binding centers of molecules of fibrinogen, fibrin and products of their proteolysis].
Grinenko TV; Tret'iachenko VG; Kudinov SA; Medved' LV
Biokhimiia; 1987 Oct; 52(10):1732-9. PubMed ID: 3427134
[TBL] [Abstract][Full Text] [Related]
26. On the molecular interactions between fibrin, tissue-type plasminogen activator and plasminogen.
Lijnen HR; Van Hoef B; Collen D
Thromb Res Suppl; 1990; 10():45-54. PubMed ID: 2107598
[TBL] [Abstract][Full Text] [Related]
27. Fibrinogen Lima: a homozygous dysfibrinogen with an A alpha-arginine-141 to serine substitution associated with extra N-glycosylation at A alpha-asparagine-139. Impaired fibrin gel formation but normal fibrin-facilitated plasminogen activation catalyzed by tissue-type plasminogen activator.
Maekawa H; Yamazumi K; Muramatsu S; Kaneko M; Hirata H; Takahashi N; Arocha-Piñango CL; Rodriguez S; Nagy H; Perez-Requejo JL
J Clin Invest; 1992 Jul; 90(1):67-76. PubMed ID: 1634621
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the factors contributing to fibrin-dependent plasminogen activation.
Mosesson MW; Siebenlist KR; Voskuilen M; Nieuwenhuizen W
Thromb Haemost; 1998 Apr; 79(4):796-801. PubMed ID: 9569195
[TBL] [Abstract][Full Text] [Related]
29. [Effect of peptides--structural analogs of NH2-terminal sites of fibrin alpha- and beta-chains--on specific binding of the NH2-terminal disulfide bond of fibrin with fibrinogen].
Pozdniakova TM; Rybalchuk VN; Il'ina AV; Davidovich IuA; Rogozhin SV
Ukr Biokhim Zh (1978); 1986; 58(2):10-5. PubMed ID: 3509954
[TBL] [Abstract][Full Text] [Related]
30. Functional characterization of monoclonal antibodies directed against fibrin binding domains of tissue-type plasminogen activator.
Wojta J; Beckmann R; Turcu L; Wagner OF; van Zonneveld AJ; Binder BR
J Biol Chem; 1989 May; 264(14):7957-61. PubMed ID: 2470738
[TBL] [Abstract][Full Text] [Related]
31. Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.
Watahiki Y; Scully MF; Ellis V; Kakkar VV
Thromb Haemost; 1989 Jun; 61(3):502-6. PubMed ID: 2508259
[TBL] [Abstract][Full Text] [Related]
32. [Binding of Glu-plasminogen by fibrinogen and byproducts of its proteolysis].
Grinenko TV; Tret'iachenko VG; Skomorovskaia EV; Kudinov SA
Biokhimiia; 1989 Feb; 54(2):213-20. PubMed ID: 2525932
[TBL] [Abstract][Full Text] [Related]
33. Effect of fibrin-like stimulators on the activation of plasminogen by tissue-type plasminogen activator (t-PA)--studies with active site mutagenized plasminogen and plasmin resistant t-PA.
Lijnen HR; Van Hoef B; De Cock F; Collen D
Thromb Haemost; 1990 Aug; 64(1):61-8. PubMed ID: 2148848
[TBL] [Abstract][Full Text] [Related]
34. Kinetic characterization of tissue-type plasminogen activator (t-PA) and t-PA deletion mutants.
de Vries C; Veerman H; Nesheim ME; Pannekoek H
Thromb Haemost; 1991 Mar; 65(3):280-5. PubMed ID: 1904654
[TBL] [Abstract][Full Text] [Related]
35. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
Doolittle RF; Pandi L
Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
[TBL] [Abstract][Full Text] [Related]
36. Biochemical and biological properties of a recombinant tissue-type plasminogen activator derived from the rat JMI-229 cell line.
Lijnen HR; Webb PD; Van Hoef B; De Cock F; Stassen JM; Prior SD; Collen D
Thromb Haemost; 1992 Feb; 67(2):239-47. PubMed ID: 1621244
[TBL] [Abstract][Full Text] [Related]
37. Binding of fibrin fragments to one-chain and two-chain tissue-type plasminogen activator.
Hasan AA; Chang WS; Budzynski AZ
Blood; 1992 May; 79(9):2313-21. PubMed ID: 1571544
[TBL] [Abstract][Full Text] [Related]
38. Binding of tissue-type plasminogen activator to fibrinogen fragments.
Bosma PJ; Rijken DC; Nieuwenhuizen W
Eur J Biochem; 1988 Mar; 172(2):399-404. PubMed ID: 3127207
[TBL] [Abstract][Full Text] [Related]
39. Soluble, cross-linked fibrin(ogen) hybrid oligomers do not stimulate t-PA conversion of plasminogen.
Grøn B; Bennick A; Filion-Myklebust C; Matsueda GR; Nieuwenhuizen W; Brosstad F
Thromb Res; 1992 May; 66(2-3):231-8. PubMed ID: 1412194
[TBL] [Abstract][Full Text] [Related]
40. Degradation of fibrinogen by tissue plasminogen activator. Consequences for fibrin polymerization.
Mirshahi M; Soria J; Soria C; Samama M; Caen JP
Thromb Res Suppl; 1990; 10():21-6. PubMed ID: 2107597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
